You just read:

Syndax Pharmaceuticals Announces Clinical Collaboration to Evaluate Entinostat in Combination with anti-PD-L1 Cancer Immunotherapy in Breast Cancer

News provided by

Syndax Pharmaceuticals

Jan 10, 2018, 07:00 ET